Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetraspan (hydroxyethyl starch) in children <36 months undergoing major surgery
2009-009116-49Phase 3Active
- Sponsor
- Istituto Giannina Gaslini
- Start
- Mar 2012
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of hydroxyethyl starch 130/0.42, sponsored by Istituto Giannina Gaslini. Primary endpoint: Arterial pressure maintenance. Started Mar 2012; status: active.
02
Drugs
hydroxyethyl starch 130/0.42
Beyond the preview
Go deeper on 2009-009116-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009116-49.